Stem cell shot aims to restore ovarian function in small safety trial
NCT ID NCT06578039
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a single injection of stem cells from donated umbilical cords is safe for women with premature ovarian insufficiency (early menopause). Only 6 women took part, and the main goal was to check for side effects, not to prove it works. Researchers also looked at hormone levels to see if there were any hints of benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREMATURE OVARIAN INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, 463-712, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Major study launches to unravel mysteries of early menopause
- DNA hunt for why some women face early menopause
- Stem cell shot into ovaries aims to tame perimenopause symptoms
- Could stem cell exosomes restore fertility? new trial tests hope for early ovarian failure
- Could pollution and sleep habits be messing with your hormones? new study investigates.
- Early menopause heart risk under microscope: hormone Therapy's role questioned